Comment
. 2007 Mar 12;167(5):513-4; author reply 514-5.
doi: 10.1001/archinte.167.5.513-b.
Risedronate for the prevention of hip fractures: concern about validity of trials
- PMID: 17353501
- DOI: 10.1001/archinte.167.5.513-b
Item in Clipboard
Comment
Risedronate for the prevention of hip fractures: concern about validity of trials
Arch Intern Med.
.
No abstract available
Comment on
-
The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial.Arch Intern Med. 2005 Aug 8-22;165(15):1737-42. doi: 10.1001/archinte.165.15.1737. Arch Intern Med. 2005. Retraction in: JAMA Intern Med. 2016 Sep 1;176(9):1256. doi: 10.1001/jamainternmed.2016.3177. PMID: 16087821 Retracted. Clinical Trial.
-
Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.Arch Intern Med. 2005 Aug 8-22;165(15):1743-8. doi: 10.1001/archinte.165.15.1743. Arch Intern Med. 2005. Retraction in: JAMA Intern Med. 2016 Sep 1;176(9):1256. doi: 10.1001/jamainternmed.2016.3771. PMID: 16087822 Retracted. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
